Sort
11,323 grants matching “glioblastoma”
Requisition of Bio-RAD QX200 Digital Droplet PCR System
$61,533Haeyoung Kim · Texas A&M University-Kingsville · R16 · FY2024 · GM
Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis
$61,486Hai Yan · Duke University · R01 · FY2011 · CA
Biophysical Interrogation of Signals that Drive GBM Invasion
$61,436Adam J Engler · University Of California, San Diego · R01 · FY2022 · NS
Role of Src family kinases in endothelial cell biology
$61,314Brian Patrick Eliceiri · University Of California, San Diego · R01 · FY2007 · HL
Investigating mechanisms of kinase-mediated cell migration in aggressive glioblastoma
$61,226Kyle P. Mohler · Yale University · F32 · FY2019 · CA
Three-dimensional characterization of epigenomic intratumoral heterogeneity in IDH-mutant glioma
$61,226Radhika Mathur · University Of California, San Francisco · F32 · FY2019 · CA
Identification of functional non-coding RNAs in Human Breast Cancer
$61,226Matthew Robert Gruner · University Of California, San Francisco · F32 · FY2019 · CA
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
$61,181Carol A Kruse · University Of California Los Angeles · R01 · FY2013 · CA
Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities
$61,174Mindy Kim Graham · Johns Hopkins University · F32 · FY2018 · CA
Cadherin Regulation of Glioma Invasion: A Biophysical Perspective
$61,174Joseph Chen · University Of California Berkeley · F32 · FY2018 · CA
Investigating CD97 blockade as a therapeutic strategy in glioblastoma
$61,174Michael Safaee · University Of California, San Francisco · F32 · FY2018 · CA
Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis
$61,116Hai Yan · Duke University · R01 · FY2012 · CA
Translational and Clinical Research
$61,003Jeffrey F Moley · Washington University · P30 · FY2014 · CA
Serotonin drives cancer stem cell maintenance and glioblastoma progression
$60,990Daniel J Silver · Cleveland Clinic Lerner Com-Cwru · F32 · FY2017 · CA
Cancer Immunotherapeutics
$60,976Peter Poon-Hang Lee · Beckman Research Institute/City Of Hope · P30 · FY2022 · CA
Cancer Immunotherapeutics
$60,976Peter Poon-Hang Lee · Beckman Research Institute/City Of Hope · P30 · FY2021 · CA
Project 05: Translational Therapeutics (TT)
$60,535David P Carbone · Ohio State University · P30 · FY2025 · CA
Translational and Clinical Research
$60,202Jeffrey F Moley · Washington University · P30 · FY2013 · CA
Solid Tumor Therapeutics (Project-007)
$60,053Timothy J Eberlein · Washington University · P30 · FY2016 · CA
Solid Tumor Therapeutics (Project-007)
$60,053Timothy J Eberlein · Washington University · P30 · FY2019 · CA
Solid Tumor Therapeutics (Project-007)
$60,053Timothy J Eberlein · Washington University · P30 · FY2017 · CA
Heat Shock Protein Vaccine Dev: Glioma immunoresistance and PI(3)K/Akt/mTOR pathw
$59,989Andrew T Parsa · University Of California, San Francisco · P50 · FY2012 · CA
The San Francisco Bay Area Adult Glioma Survival Study
$59,989Margaret R. Wrensch · University Of California, San Francisco · P50 · FY2012 · CA
Exploiting the P13 Kinase Pathway in Human Glioma Therapy
$59,989David H Stokoe · University Of California, San Francisco · P50 · FY2012 · CA
Ph I Radiation and Lenalidomide in pediatric malignant glioma
$59,349Katherine E Warren · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA